Skip to main content

BioRestorative Therapies, Inc.

BRTX
Exchange
Nasdaq
Industry
Services-Misc Health & Allied Services, NEC
SEC CIK
0001505497

No open-market purchases or sales by BioRestorative Therapies, Inc. insiders were filed in the last 90 days; 23 institutions reported holding it in 13F filings for Q2 2026, worth $1.00M in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by BioRestorative Therapies, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for BioRestorative Therapies, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for BioRestorative Therapies, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Silva FranciscoVP of Research and Development171,384Oct 20, 20251
Alstodt LancePresident, CEO, COB187,497Oct 20, 20251
Rosa David ADirector–Feb 19, 20250
Williams Patrick F.Director–Feb 19, 20250
Kukekov Nickolay V.Director–Feb 19, 20250
Kristal Robert EugeneChief Financial Officer7,994Feb 19, 20250
Broadrick Dale10% Owner445,933Nov 5, 20240
Paccasassi RobertVP, QA and Reg Compliance–Feb 15, 20240

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jun 6, 2022 (view filing)Jun 24 daysBroadrick Dale10% OwnerPPurchase+1.00K$4.69+$4.69K+0.4%278.5K after
Jun 3, 2022 (view filing)Jun 12 daysBroadrick Dale10% OwnerPPurchase+9.21K$4.46+$41.1K+3.4%277.5K after
Jun 3, 2022 (view filing)Jun 12 daysAlstodt LancePresident, CEO, COBPPurchase+200$4.60+$920+0.1%178.8K after
Jun 1, 2022 (view filing)May 275 daysBroadrick Dale10% OwnerPPurchase+11.0K$3.61+$39.6K+4.3%268.3K after
May 31, 2022 (view filing)May 265 daysBroadrick Dale10% OwnerPPurchase+4.95K$3.51+$17.4K+1.9%259.3K after
May 31, 2022 (view filing)May 265 daysBroadrick Dale10% OwnerSSale−2.00K$3.44−$6.88K−0.8%257.3K after
May 27, 2022 (view filing)May 261 dayAlstodt LancePresident, CEO, COBPPurchase+2.70K$3.52+$9.50K+1.5%178.6K after
May 2, 2022 (view filing)May 2Same dayAlstodt LancePresident, CEO, COBPPurchase+400$3.95+$1.58K+0.2%175.9K after2 lots
Apr 11, 2022 (view filing)Apr 83 daysKristal Robert EugeneChief Financial OfficerPPurchase+7.60K$5.71+$43.4KNew position7.60K after
Apr 8, 2022 (view filing)Apr 62 daysBroadrick Dale10% OwnerPPurchase+2.50K$5.66+$14.2K+1.0%254.4K after
Apr 7, 2022 (view filing)Apr 52 daysBroadrick Dale10% OwnerPPurchase+46.0K$5.71+$262.6K+22.3%251.9K after2 lots
Apr 1, 2022 (view filing)Mar 29-313 daysLateBroadrick Dale10% OwnerPPurchase+15.7K$4.85+$76.1K+5.2%317.0K after3 lots
Mar 29, 2022 (view filing)Mar 1-428 daysLateBroadrick Dale10% OwnerPPurchase+101.6K$5.54+$562.6K+50.9%301.3K after4 lots
Mar 29, 2022 (view filing)Mar 7-2122 daysLateBroadrick Dale10% OwnerPPurchase+54.4K$4.26+$231.6K+35.9%205.9K after4 lots
Jan 24, 2022 (view filing)Jan 24Same dayAlstodt LancePresident, CEO, COBPPurchase+1.47K$3.40+$5.00K+0.9%163.1K after
Jan 5, 2022 (view filing)Jan 5Same dayAlstodt LancePresident, CEO, COBPPurchase+2.00K$3.85+$7.70K+1.3%161.6K after
Dec 2, 2021 (view filing)Dec 11 dayAlstodt LancePresident, CEO, COBPPurchase+799$5.50+$4.39K+0.5%159.6K after
Nov 23, 2021 (view filing)Nov 23Same dayAlstodt LancePresident, CEO, COBPPurchase+2.50K$6.00+$15.0K+1.6%158.8K after
Nov 22, 2021 (view filing)Nov 22Same dayAlstodt LancePresident, CEO, COBPPurchase+396$6.31+$2.50K+0.3%156.3K after
Nov 22, 2021 (view filing)Nov 193 daysSilva FranciscoVP of Research and DevelopmentPPurchase+4.00K$6.66+$26.6K+51.1%11.8K after
Nov 16, 2021 (view filing)Nov 16Same dayAlstodt LancePresident, CEO, COBPPurchase+4.50K$6.71+$30.2K+3.0%155.9K after4 lots
Nov 16, 2021 (view filing)Nov 16Same daySilva FranciscoVP of Research and DevelopmentPPurchase+7.83K$6.73+$52.7K+260,866.7%7.83K after2 lots